Investigation of tumor tissue alteration after experimental chemotherapy

Investigation of tumor tissue alteration after experimental chemotherapy

The aim of the present work was the study of tumor tissue alteration after new antineoplastic substance administration in comparison with widely investigated 5-fluorouracil. White rats bearing Plisse lymphosarcoma, sarcoma 45, Walker carcino-sarcoma, sarcoma 180 were used in the study. Pieces of tum...

Full description

Bibliographic Details
Main Author:	Grygorieva E. V.
Format:	Article
Language:	Russian
Published:	Ministry of Health of Ukraine. Dnipropetrovsk Medical Academy 2009-01-01
Series:	Морфологія
Subjects:	fluoropyrimidines histology apoptosis necrosis mitosis
Online Access:	http://www.morphology.dp.ua/_pub/MORPHO-2009-03-04/09gevpec.pdf

Similar Items

TEYSUNO: FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH DISSEMINATED GASTRIC CANCER
by: O. O. GORDEEVA, et al.
Published: (2017-06-01)

Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors
by: Laura Grumetti, et al.
Published: (2022-01-01)

Management of cytotoxic chemotherapy-induced hand-foot syndrome
by: Johannes J.M. Kwakman, et al.
Published: (2020-05-01)

Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma
by: Saelen Marie, et al.
Published: (2012-09-01)

Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer
by: N. S. Besova, et al.
Published: (2019-06-01)

The puzzling clinical presentation of fluoropyrimidines cardiotoxicity
by: Linda Cucciniello, et al.
Published: (2022-09-01)

The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection
by: Young Saing Kim, et al.
Published: (2017-01-01)

The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study
by: Edoardo Francini, et al.
Published: (2021-02-01)

Risk of cardiovascular disease among different fluoropyrimidine-based chemotherapy regimens as adjuvant treatment for resected colorectal cancer
by: Wen-Kuan Huang, et al.
Published: (2022-08-01)

Hypertriglyceridemia Induced by Fluorouracil: A Novel Case Report
by: Yoshitaka Saito, et al.
Published: (2021-03-01)

Fluoropyrimidine chemotherapy: recommendations for DPYD genotyping and therapeutic drug monitoring of the Swiss Group of Pharmacogenomics and Personalised Therapy
by: Seid Hamzic, et al.
Published: (2020-11-01)

Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
by: William H. Gmeiner
Published: (2024-03-01)

Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine‐induced toxicity in an Asian population
by: Masashi Kanai, et al.
Published: (2023-04-01)

Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
by: Georgia Ragia, et al.
Published: (2023-09-01)

Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients
by: Xianwei Mo, et al.
Published: (2020-01-01)

A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer
by: Miguel Cordova-Delgado, et al.
Published: (2021-09-01)

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene
by: García-González X, et al.
Published: (2018-10-01)

Enhanced Therapeutic Efficacy of the Nanoscale Fluoropyrimidine Polymer CF10 in a Rat Colorectal Cancer Liver Metastasis Model
by: Charles Chidi Okechukwu, et al.
Published: (2024-03-01)

Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis
by: Yajie Lu, et al.
Published: (2023-03-01)

A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening
by: Chi C. Tong, et al.
Published: (2018-07-01)

A Pyranoxanthone as a Potent Antimitotic and Sensitizer of Cancer Cells to Low Doses of Paclitaxel
by: Fábio França, et al.
Published: (2020-12-01)

A Review of Potential Role of Capsule Endoscopy in the Work-Up for Chemotherapy-Induced Diarrhea
by: Takayuki Ando, et al.
Published: (2022-01-01)

Potential Impact of DPYD Variation on Fluoropyrimidine Drug Response in sub-Saharan African Populations
by: Jorge E. B. da Rocha, et al.
Published: (2021-03-01)

Zingerone Suppresses Tumor Development through Decreasing Cyclin D1 Expression and Inducing Mitotic Arrest
by: Jae-Sun Choi, et al.
Published: (2018-09-01)

Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia
by: N. S. Besova, et al.
Published: (2019-12-01)

E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer
by: Haibo Wang, et al.
Published: (2022-07-01)

<i>DPYD</i> and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
by: Theodore J. Wigle, et al.
Published: (2019-05-01)

Dissecting mitosis by RNAi in Drosophila tissue culture cells
by: Maiato Helder, et al.
Published: (2003-01-01)

In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase
by: Eiji Hishinuma, et al.
Published: (2020-07-01)

The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease
by: Natalia Fabin, et al.
Published: (2022-02-01)

Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
by: Anthi Maslarinou, et al.
Published: (2023-05-01)

HPV16-E7 Expression Causes Fluorodeoxyuridine-mediated Radiosensitization in SW620 Human Colon Cancer Cells
by: Michael D. Axelson, et al.
Published: (1999-06-01)

Treatment-Related Coronary Disorders of Fluoropyrimidine Administration: A Systematic Review and Meta-Analysis
by: Yajie Lu, et al.
Published: (2022-05-01)

Rare Dihydropyrimidine Dehydrogenase Variants and Toxicity by Floropyrimidines: A Case Report
by: Raffaele Palmirotta, et al.
Published: (2019-03-01)

Variación en los índices de mitosis y apoptosis del epitelio uterino de la coneja durante los días previos a la implantación
by: Santiago René Anzaldúa Arce, et al.
Published: (2012-01-01)

To Ubiquitinate or Not to Ubiquitinate: TRIM17 in Cell Life and Death
by: Meenakshi Basu-Shrivastava, et al.
Published: (2021-05-01)

BP-M345, a New Diarylpentanoid with Promising Antimitotic Activity
by: Pedro Novais, et al.
Published: (2021-11-01)

Cellular responses to a prolonged delay in mitosis are determined by a DNA damage response controlled by Bcl-2 family proteins
by: Didier J. Colin, et al.
Published: (2015-01-01)

Mapping Mitotic Death: Functional Integration of Mitochondria, Spindle Assembly Checkpoint and Apoptosis
by: Weimei Ruan, et al.
Published: (2019-01-01)

Cell death in cancer chemotherapy using taxanes
by: Ana P. Xu, et al.
Published: (2024-01-01)